| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |